REQUEST A DEMO
Total
USD $0.00
Search more companies

Alphabed Kft. (Hungary)

Main Activities: Mattress Manufacturing
Full name: Alphabed Biomanufaktura Kereskedelmi es Szolgaltato Kft. Profile Updated: February 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

NOVETEX MATRAC Biomanufaktúra, based in Budapest, Hungary, develops and utilizes flexible latex mattresses with ventilation and hygiene features. The company offers a range of mattresses, including the Vitality Sens Premium talalay latex gel mattress and the VIROCLEAN matrachuzat with reducing viral activity treatment.

Headquarters
Ulloi ut 95.
Budapest; Budapest; Postal Code: 1091

Contact Details: Purchase the Alphabed Kft. report to view the information.

Website: http://www.matrac.hu

Basic Information
Total Employees:
Purchase the Alphabed Kft. report to view the information.
Outstanding Shares:
Purchase the Alphabed Kft. report to view the information.
Registered Capital:
Purchase the Alphabed Kft. report to view the information.
Financial Auditors:
Purchase the Alphabed Kft. report to view the information.
Incorporation Date:
June 01, 2000
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Gala-Flex Ruhakeszito Es Forgalmazo Korlatolt Felelossegu Tarsasag
Company Performance
Financial values in the chart are available after Alphabed Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.21%
Total operating revenue
13.71%
Operating profit (EBIT)
59.82%
EBITDA
54.71%
Net Profit (Loss) for the Period
27.54%
Total assets
9.37%
Total equity
12.05%
Operating Profit Margin (ROS)
1.07%
Net Profit Margin
0.21%
Return on Equity (ROE)
1.3%
Quick Ratio
0.03%
Cash Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?